Ambalal Sarabhai Enterprises Ltd.
| BSE: 500009 | Sector: Health care |
| NSE: AMBASARABH | ISIN Code: INE432A01017 |
| BSE 12:10 | 27 Sep | 31.20 |
-0.25 (-0.79%) |
OPEN
31.15 |
HIGH
31.95 |
LOW
30.55 |
| NSE 05:30 | 01 Jan | Ambalal Sarabhai Enterprises Ltd |
| OPEN | 31.15 |
| PREVIOUS CLOSE | 31.45 |
| VOLUME | 100986 |
| 52-Week high | 65.00 |
| 52-Week low | 16.55 |
| P/E | 12.48 |
| Mkt Cap.(Rs cr) | 239 |
| Buy Price | 31.00 |
| Buy Qty | 163.00 |
| Sell Price | 31.20 |
| Sell Qty | 12713.00 |
Ambalal Sarabhai Enterprises Ltd. (AMBASARABH) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 764.75 | -0.64 | 804.40 | 452.60 | 183486.46 |
| Divi's Lab. | 4955.75 | -2.86 | 5269.00 | 2986.70 | 131550.38 |
| Dr Reddy's Labs | 4760.00 | -0.68 | 5613.65 | 4135.90 | 79206.40 |
| Cipla | 960.25 | -0.70 | 997.20 | 706.45 | 77458.57 |
| Piramal Enterp. | 2769.90 | -0.09 | 2856.80 | 1178.85 | 66103.66 |
| Apollo Hospitals | 4548.10 | -3.90 | 5183.30 | 1762.40 | 65392.58 |
| Gland Pharma | 3856.40 | 0.23 | 4350.00 | 1701.00 | 63322.09 |
| Cadila Health. | 556.90 | -1.39 | 673.70 | 373.95 | 57009.85 |
| Torrent Pharma. | 3083.00 | -0.56 | 3226.05 | 2311.30 | 52170.53 |
| Alkem Lab | 4008.85 | 0.17 | 4067.70 | 2544.25 | 47925.80 |
| Abbott India | 21260.00 | 0.33 | 21850.00 | 13970.10 | 45177.50 |
| Biocon | 359.00 | -0.33 | 487.70 | 327.75 | 43101.54 |
| Aurobindo Pharma | 717.40 | -0.65 | 1063.75 | 660.10 | 42032.47 |
| Lupin | 924.35 | -0.20 | 1267.50 | 856.00 | 41970.11 |
| Max Healthcare | 357.00 | -2.23 | 472.60 | 102.50 | 34484.42 |
| Laurus Labs | 596.10 | -2.25 | 723.55 | 249.29 | 31986.73 |
| Dr Lal Pathlabs | 3754.40 | -3.50 | 4243.00 | 1762.40 | 31289.17 |
| Ipca Labs. | 2403.05 | 0.04 | 2767.10 | 1786.05 | 30482.69 |
| Syngene Intl. | 652.00 | 1.10 | 699.95 | 490.35 | 26132.16 |
| Pfizer | 5650.25 | -0.96 | 6164.80 | 4200.00 | 25849.89 |
Quick Links for Ambalal Sarabhai Enterprises:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
